AmCAD-UO、AmCAD-UT

 

Category: Medical Devices

Exhibitor: DEPARTMENT OF SOCIAL WELFARE, TAIPEI CITY GOVERNMENT

Booth No: N402

 

Characteristic

 

AmCAD-UO is the world’s first AI-enabled solution for fast and accurate obstructive sleep apnea (OSA) risk assessment. Its technology supports clinical decision-making throughout the journey. Product highlights include:
* Rapid Insights with 95% Accuracy: Offer upper airway detailed & non-invasive insights into OSA risk factors
* Visualization & Quantification for Informed Decisions: Help customize treatments like MADs or HNS using patient-specific data
* Tailored Treatment Plans: Provides measurable feedback for personalized treatment adjustments
AmCAD-UT is an AI-powered thyroid ultrasound software that detects, analyzes, and reports nodules with TI-RADS support – streamlining workflow with minimal manual input. Product highlights include:
* Real-time Guidance: AI-powered real-time guidance for identifying thyroid structure and alerting suspicious findings
* Advanced Nodule Visualization: Comprehensive analysis with detailed display of nodule characteristics
* TI-RADS Integration: Automated risk stratification using the user selected TI-RADS from 8 TI-RADS selections

 

Other Products

 

• 

  Macroinsight Innovation-MacroPACS AI platform

• 

  ACT Genomics Co. Ltd-NGS Cancer Genomics Testing

• 

  GENETICS GENERATION ADVANCEMENT CORP. (GGA CORP.)-AI-powered Exosomal miRNA Precision Target Analysis Platform

• 

  TaiHao Medical Inc.-TaiHao Med AI Solution

• 

  Lilia Neuro

• 

  AI-Powered Innovation: Designing the Next-Gen Degrader Therapeutics

• 

  Stress EEG Assessment System

• 

  V5med Lung AI

• 

  Nano CASTᵀᴹ Cancer Solution

 

 

 

Back